RecallDepth
Class II Terminated

Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa Medicare Limited Jadcherla -509301 INDIA Distributed by: Cipla USA, Inc. 10 Independence Blvd, Suite 300 Warren, NJ 07059 NDC 69097-805-40

This recall has been terminated (originally issued December 23, 2020).

Company
Cipla
Recall Initiated
December 14, 2020
Posted
December 23, 2020
Recall Number
D-0165-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2151 vials
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP deviations: Vials may not be sealed correctly affecting sterility.

Distribution

USA Nationwide

Lot / Code Info

Lot #: 7S10182A, Ex 9/2021

More recalls by Cipla

View all recalls by this company →

Other recent Class II Drug recalls